Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma

BACKGROUND: Recurrent hepatitis C virus (HCV) infection of transplanted liver allografts is universal in patients with detectable HCV viremia at the time of transplantation. Direct-acting antiviral (DAA) therapy has been adopted as the standard of care for recurrent HCV infection in the post-transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Mohamed Saleh, Hassan, Manal, Khaderi, Saira Aijaz, Yousry, Wael Ahmed, Kamal El-Din, Maha Mohsen, Bahaa El-Din, Mohamed Mohamed, El Sayed, Osama Aboelfotoh, Kaseb, Ahmed Omar, Goss, John Alan, Kanwal, Fasiha, Jalal, Prasun Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522560/
https://www.ncbi.nlm.nih.gov/pubmed/33033569
http://dx.doi.org/10.4254/wjh.v12.i9.628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522560/
https://www.ncbi.nlm.nih.gov/pubmed/33033569
http://dx.doi.org/10.4254/wjh.v12.i9.628

Ejemplares similares